The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 297, Issue 6, 2009, Pages

  Sturgis, LaShon C ^a   Cannon, Joseph G ^a   Schreihofer, Derek A ^a   Brands, Michael W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Angiotensin II; Bioactivity

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; DEOXYCORTICOSTERONE ACETATE; INTERLEUKIN 6; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BIOASSAY; BIOLOGICAL ACTIVITY; BLOOD PRESSURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MEGADOSE; ENZYME IMMUNOASSAY; HYBRIDOMA CELL CULTURE; HYPERTENSION; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TELEMETRY; WILD TYPE;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANGIOTENSINS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; HYPERTENSION; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, SUBCUTANEOUS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SPIRONOLACTONE; TIME FACTORS;

EID: 72449162049     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.90995.2008     Document Type: Article

References (40)

1. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 17: 1411-1416, 1987. (Pubitemid 17161193)
2. Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy U.S. adults. Hypertension 39: 197-202, 2002. (Pubitemid 34165214)
3. Banes AK, Watts SW. Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension. BMC Pharmacol 3: 12-26, 2003.
4. Barbieri M, Ferrucci L, Corsi AM, Macchi C, Lauretani F, Bonafe M, Olivieri F, Giovagnetti S, Franceschi C, Paolisso G. Is chronic inflammation a determinant of blood pressure in the elderly? Am J Hypertens 16: 537-543, 2003. (Pubitemid 36829702)
5. Brasier AR, Recinos A, 3rd, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 22: 1257-1266, 2002.
6. Call JT, Deliargyris EN, Newby LK. Focusing on inflammation in the treatment of atherosclerosis. Cardiol Rev 12: 194-200, 2004.
7. Carretero OA, Scicli AG. Local hormonal factors (intracrine, autocrine, and paracrine) in hypertension. Hypertension 18 Suppl. I: I-58 -I-69, 1991.
8. Cassis LA, Helton MJ, Howatt DA, King VL, Daugherty A. Aldosterone does not mediate Angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Br J Pharmacol 144: 443-448, 2005. (Pubitemid 40313692)
9. Coles B, Fielding CA, Rose-John S, Scheller J, Jones SA, O'Donnell VB. Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control Angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo. Am J Pathol 171: 315-325, 2007. (Pubitemid 47339248)
10. Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98: 121-128, 2006.
11. Franchimont N, Lambert C, Huynen P, Ribbens C, Relic B, Chariot A, Bours V, Piette J, Merville MP, Malaise M. Interleukin-6 receptor shedding is enhanced by interleukin-1β and tumor necrosis factor β and is partially mediated by tumor necrosis factor α-converting enzyme in osteoblast-like cells. Arthritis Rheum 52: 84-93, 2005. (Pubitemid 40129236)
12. Funakoshi Y, Ichiki T, Ito K, Takeshita A. Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension 34: 118-125, 1999. (Pubitemid 29325729)
13. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460, 2007. (Pubitemid 47529329)
14. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20, 2003. (Pubitemid 37046923)
15. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334: 297-314, 1998. (Pubitemid 28448572)
16. Hoeper MM, Welte T. Systemic inflammation, COPD, and pulmonary hypertension. Chest 131: 634-635; author reply 635, 2007. (Pubitemid 46280433)
17. Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM. Aldosterone mediates ANG iotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J 20: 1546-1548, 2006.
18. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol 13: 2860-2868, 2002. (Pubitemid 35386905)
19. Keller ET, Wanagat J, Ershler WB. Molecular and cellular biology of interleukin-6 and its receptor. Front Biosci 1: 340-357, 1996.
20. Ko EA, Amiri F, Pandey NR, Javeshghani D, Leibovitz E, Touyz RM, Schiffrin EL. Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice. Am J Physiol Heart Circ Physiol 292: H1789-H1795, 2007.
21. Kranzhofer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 1623-1629, 1999. (Pubitemid 29323820)
22. Lee DL, Sturgis LC, Labazi H, Osborne JB Jr, Fleming C, Pollock JS, Manhiani M, Imig JD, Brands MW. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am J Physiol Heart Circ Physiol 290: H935-H940, 2006.
23. Li JJ, Fang, CH, Hui RT. Is hypertension an inflammatory disease? Med Hypotheses 64: 236-240, 2005.
24. Luther JM, Gainer JV, Murphey LJ, Yu C, Vaughan DE, Morrow JD, Brown NJ. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension 48: 1050-1057, 2006. (Pubitemid 44772707)
25. Manhiani MM, Quigley JE, Socha MJ, Motamed K, Imig JD. IL6 suppression provides renal protection independent of blood pressure in a murine model of salt-sensitive hypertension. Kidney Blood Press Res 30: 195-202, 2007. (Pubitemid 47076216)
26. Muller DN, Mervaala EM, Schmidt F, Park JK, Dechend R, Genersch E, Breu V, Loffler BM, Ganten D, Schneider W, Haller H, Luft FC. Effect of bosentan on NF-κB, inflammation, and tissue factor in angiotensin II-induced end-organ damage. Hypertension 36: 282-290, 2000. (Pubitemid 30627001)
27. Nakatani M, Seki T, Shinohara Y, Taki C, Nishimura S, Takaki A, Shioda S. Pituitary adenylate cyclase-activating peptide (PACAP) stimulates production of interleukin-6 in rat Muller cells. Peptides 27: 1871-1876, 2006.
28. Nishioka T, Suzuki M, Onishi K, Takakura N, Inada H, Yoshida T, Hiroe M, Imanaka-Yoshida K. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation. J Cardiovasc Pharmacol 49: 261-268, 2007. (Pubitemid 46855118)
29. Ormsbee HS, 3rd, Ryan CF. Production of hypertension with desoxycorticorticosterone acetate-impregnated silicone rubber implants. J Pharm Sci 62: 255-257, 1973.
30. Osawa H, Yamabe H, Inuma H, Miyata M, Sasaki T, Kaizuka M, Tamura N, Tsunoda S, Fujita Y, Kanazawa T, Nomura K, Onodera K. TGF-β upregulates interleukin 6 production by rat glomerular epithelial cells in vitro. Nephrol Dial Transplant 10: 1592-1597, 1995.
31. Rhaleb NE, Peng H, Alfie ME, Shesely EG, Carretero OA. Effect of ACE inhibitor on DOCA-salt- and aortic coarctation-induced hypertension in mice: do kinin B2 receptors play a role? Hypertension 33: 329-334, 1999. (Pubitemid 29065680)
32. Rose-John S, Scheller J, Elson G, Jones SA. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80: 227-236, 2006. (Pubitemid 44835496)
33. Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens 15: 152-158, 2006.
34. Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol 63: 321-329, 2006.
35. Schwabe M, Cox GW, Bosco MC, Prohaska R, Kung HF. Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation. Cell Immunol 168: 117-121, 1996. (Pubitemid 26084391)
36. Skurk T, van Harmelen V, Hauner H. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-κB. Arterioscler Thromb Vasc Biol 24: 1199-1203, 2004. (Pubitemid 38880008)
37. Tenhumberg S, Waetzig GH, Chalaris A, Rabe B, Seegert D, Scheller J, Rose-John S, Grotzinger J. Structure guided optimization of the interleukin-6 transsignaling antagonist sgp130. J Biol Chem 283: 27200-27207, 2008.
38. Virdis A, Schiffrin EL. Vascular inflammation: a role in vascular disease in hypertension? Curr Opin Nephrol Hypertens 12: 181-187, 2003. (Pubitemid 36288319)
39. Zhang, C, Chen H, Xie HH, Shu H, Yuan WJ, Su DF. Inflammation is involved in the organ damage induced by sinoaortic denervation in rats. J Hypertens 21: 2141-2148, 2003. (Pubitemid 38296876)
40. Zoccali C, Maio R, Tripepi G, Mallamaci F, Perticone F. Inflammation as a mediator of the link between mild to moderate renal insufficiency and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 17: S64-S68, 2006.